Strategic research in life sciences and biotechnology

[searchwp_form id="3"]

Callewaert Lab

Engineering next‑gen molecules to fine‑tune the immune response.

This lab designs and synthesizes novel peptides and small molecules that selectively enhance or suppress immune pathways. Through in vitro screening and animal models, they optimize candidates for treating autoimmune disorders and improving vaccine efficacy.

Profile picture Nico Callewaert

This Is the Team Heading

Team description goes here

News Heading Goes Here

Publications accent heading

Publications Goes Here

Publications description goes here

  • 22-03-2025

    Fight to Survive: Marchantia Synthesizes Newly Identified Metabolites in Response to Wounding.

    Lorem eiusmod labore dolore consectetur aliqua. labore . sit sit magna elit . dolor incididunt tempor sit et tempor incididunt . do ut eiusmod elit . sit aliqua. do incididunt aliqua. dolor magna .

    elit consectetur Lorem amet ut ipsum . magna incididunt amet do dolore elit ut . elit ipsum elit sit incididunt consectetur aliqua. . incididunt dolor dolor dolor dolor dolore . tempor adipiscing amet amet .

    Lorem sed elit tempor sed . tempor consectetur incididunt magna . incididunt sed sit amet adipiscing magna do ipsum . tempor sed labore dolor elit ipsum dolore . sed (...)

  • 03-03-2025

    Replication Stress, Microcephalic Primordial Dwarfism, and Compromised Immunity in Atrip Deficient Patients.

    Lorem eiusmod labore dolore consectetur aliqua. labore . sit sit magna elit . dolor incididunt tempor sit et tempor incididunt . do ut eiusmod elit . sit aliqua. do incididunt aliqua. dolor magna .

    elit consectetur Lorem amet ut ipsum . magna incididunt amet do dolore elit ut . elit ipsum elit sit incididunt consectetur aliqua. . incididunt dolor dolor dolor dolor dolore . tempor adipiscing amet amet .

    Lorem sed elit tempor sed . tempor consectetur incididunt magna . incididunt sed sit amet adipiscing magna do ipsum . tempor sed labore dolor elit ipsum dolore . sed (...)

  • 18-03-2010

    Impact of Elevation of Total Bilirubin Level and Etiology of the Liver Disease on Serum N-glycosylation Patterns in Mice and Humans

    The GlycoFibroTest and GlycoCirrhoTest are noninvasive alternatives for liver biopsy that can be used as a follow-up tool for fibrosis patients and to diagnose cirrhotic patients, respectively. These tests are based on the altered N-glycosylation of total serum protein. Our aim was to investigate the impact of etiology on the alteration of N-glycosylation and whether other characteristics of liver patients could have an influence on N-glycosylation. In human liver patients, no specific alteration could be found to make a distinction according to etiological factor, although alcoholic patients had a significant higher mean value for the GlycoCirrhoTest. Undergalactosylation did (...)

Why Not Join Us?

Our Research Groups

Research groups accent heading

Research groups description goes here

Custom Title for Research Projects

Research Projects Accent Heading

Research projects description goes here

  • Patient‑derived Organoid Platforms for Personalized Medicine

    Using organoid cultures to predict individualized drug responses.

    By growing mini‑organs from patient biopsy samples, we create high‑throughput drug screens tailored to each individual’s tumor or genetic disease. Integrated genomic and pharmacodynamic analyses will pinpoint optimal therapies. This approach seeks to streamline personalized treatment decisions in clinical settings.

Related Labs Heading

Related labs accent heading

Related labs description goes here

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.